B

bluebird bio

BLUE

1.08000
USD
-0.06
(-5.26%)
Market Open
Volume
18,590
EPS
0
Div Yield
0
P/E
-0
Market Cap
95,696,354
Related Instruments
A
ABIO
-0.06000
(-1.97%)
2.98000 USD
B
BLUE
-0.06000
(-5.26%)
1.08000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
V
VYGR
-0.59000
(-6.37%)
8.67000 USD
News

Title: bluebird bio

Sector: Healthcare
Industry: Biotechnology
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.